Literature DB >> 4143015

Clinical significance of T-cells in chronic lymphocytic leukaemia.

D Catovsky, E Miliani, A Okos, D A Galton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4143015     DOI： 10.1016/s0140-6736(74)90944-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  [Lymphocyte in chronic lymphatic leukemia].

Authors:  G Brittinger; W Augener; K Bremer; G Cohnen; S Dabag; K Fischer; E König; P Meusers
Journal:  Blut       Date:  1975-05

2.  Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease.

Authors:  Shahryar Kiaii; Aniruddha Choudhury; Fariba Mozaffari; Eva Kimby; Anders Osterborg; Håkan Mellstedt
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 3.  Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.

Authors:  A Winkelstein; P S Jordan
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

4.  T cells in chronic lymphatic leukaemia.

Authors:  G Semenzato; G Amadori; F Tosato; G Gasparotto
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

Review 5.  Growth and survival of B-chronic lymphocytic leukaemia cells.

Authors:  O Söderberg
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

6.  Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eµ-TCL1 CLL mouse model.

Authors:  Fabienne McClanahan; John C Riches; Shaun Miller; William P Day; Eleni Kotsiou; Donna Neuberg; Carlo M Croce; Melania Capasso; John G Gribben
Journal:  Blood       Date:  2015-05-15       Impact factor: 22.113

7.  DNA-synthesizing T and non-T cells in chronic lymphocytic leukemia.

Authors:  J A van der Woerd- de Lange; J Döhrmann; C Huber; P Schick; K Rauert; H Begemann
Journal:  Blut       Date:  1978-12-15

8.  T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia.

Authors:  H R Toben; R G Smith
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

9.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

10.  Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics.

Authors:  Candida Vitale; Lorenzo Falchi; Elisa Ten Hacken; Hui Gao; Hila Shaim; Katrien Van Roosbroeck; George Calin; Susan O'Brien; Stefan Faderl; Xuemei Wang; William G Wierda; Katayoun Rezvani; James M Reuben; Jan A Burger; Michael J Keating; Alessandra Ferrajoli
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.